Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion, EMT, ROS production, and decreased CXCR4 and IL-6 receptor expression through MAOA/mTOR/HIF-1α signaling53. This evidence concerns the gene CXCR4 and prostate carcinoma.